EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa

Philip J Rosenthal iD, Victor Asua iD, Melissa D Conrad iD

Nature Reviews Microbiology · 2024-06 · 22 (6) · 373-384

DOI: 10.1038/s41579-024-01008-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nature Reviews Microbiology, online erschienen am 06.02.2024. Verfasst von Philip J Rosenthal und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco, CA, USA. philip.rosenthal@ucsf.edu. Hauptthemen laut MEDLINE: Artemisinins, Drug Resistance, Malaria, Falciparum, Plasmodium falciparum. Die Arbeit wurde bisher 182-mal zitiert (Crossref) und nennt 144 Literaturangaben. Gefördert von: NIAID NIH HHS, Bill and Melinda Gates.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria, mostly due to Plasmodium falciparum infection in Africa, remains one of the most important infectious diseases in the world. Standard treatment for uncomplicated P. falciparum malaria is artemisinin-based combination therapy (ACT), which includes a rapid-acting artemisinin derivative plus a longer-acting partner drug, and standard therapy for severe P. falciparum malaria is intravenous artesunate. The efficacy of artemisinins and ACT has been threatened by the emergence of artemisinin partial resistance in Southeast Asia, mediated principally by mutations in the P. falciparum Kelch 13 (K13) protein. High ACT treatment failure rates have occurred when resistance to partner drugs is also seen. Recently, artemisinin partial resistance has emerged in Rwanda, Uganda and the Horn of Africa, with independent emergences of different K13 mutants in each region. In this Review, we summarize our current knowledge of artemisinin partial resistance and focus on the emergence of resistance in Africa, including its epidemiology, transmission dynamics and mechanisms. At present, the clinical impact of emerging resistance in Africa is unclear and most available evidence suggests that the efficacies of leading ACTs remain excellent, but there is an urgent need to better appreciate the extent of the problem and its consequences for the treatment and control of malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsDrug ResistanceMalaria, FalciparumPlasmodium falciparumAntimalarialsHumansAfricaProtozoan ProteinsMutation

Substanzen

ArtemisininsAntimalarialsProtozoan Proteinsartemisinin

Autor:innen und Institutionen

  • University of California, San Francisco, CA, USA. philip.rosenthal@ucsf.edu.
  • Infectious Diseases Research Collaboration, Kampala, Uganda.
  • University of Tübingen, Tübingen, Germany.
  • University of California, San Francisco, CA, USA.

ORCID-Profile: Philip J Rosenthal, Victor Asua, Melissa D Conrad

Förderung

  • NIAID NIH HHS
  • Bill and Melinda Gates

Zitieren

APA

Rosenthal, P. J., Asua, V., & Conrad, M. D. (2024). Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. Nature Reviews Microbiology, 22(6), 373-384. https://doi.org/10.1038/s41579-024-01008-2

Vancouver

Rosenthal PJ, Asua V, Conrad MD. Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. Nature Reviews Microbiology. 2024;22(6):373-384. doi:10.1038/s41579-024-01008-2

BibTeX
@article{Rosenthal2024,
  author = {Rosenthal, Philip J and Asua, Victor and Conrad, Melissa D},
  title = {Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa},
  journal = {Nature Reviews Microbiology},
  year = {2024},
  volume = {22},
  number = {6},
  pages = {373--384},
  doi = {10.1038/s41579-024-01008-2}
}
Kostenlos starten →